Fluvoxamine May Reduce Long COVID Fatigue, Study Finds
A recently published study suggests that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and obsessive-compulsive disorder, may reduce persistent fatigue experienced by some individuals following ... Read More